Evidence check: CYP2C19 in the context of skin aging

CYP2C19 is a cytochrome P450 enzyme primarily involved in drug metabolism (e.g., clopidogrel, proton pump inhibitors). There is no robust scientific evidence directly linking CYP2C19 genetic variants to skin aging. Skin aging is driven by UV exposure, oxidative stress, collagen degradation, hormonal changes, and lifestyle factors. While CYP2C19 could theoretically influence the metabolism of endogenous compounds or environmental toxins that affect skin, this remains speculative and mechanistic. Direct-to-consumer tests claiming a role for CYP2C19 in skin aging lack clinical validation. Consumers should be cautious: such genetic markers are not established predictors of skin aging. Proven interventions—sunscreen, antioxidants, retinoids, and a healthy diet—are far more impactful. The evidence level is unclear/mechanistic at best.